News & events
Press Releases
On the 28th March 2022, OncoArendi changed its name to Molecure
OncoArendi Therapeutics supervisory board welcomes international biopharmaceutical experts: Nancy Van Osselaer, Paul van der Horst and Rafal Kamiński as its new members
14 January 2022
OncoArendi continues to grow by executing further steps of the strategy and initiates two new drug discovery programs within its existing research platforms
19 August 2021
Galapagos informed about the initiation of a clinical trial to evaluate potential pharmacokinetic interactions of GLPG4716
21 July 2021
OncoArendi executes the strategy for 2021-2025 in the area of R&D platform for developing small molecules modulating RNA function
16 June 2021
OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhibitors in fibrosis
5 November 2020
American Journal of Medicinal Chemistry distinguishes OncoArendi publication on OATD-01
21 October 2020